CeriBell (CBLL) vs CONMED (CNMD)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 7, 2026.
Summary
CONMED is the larger company by market cap ($1.32 billion vs $901.1 million), about 1.5 times the size. CONMED pays a dividend yielding 0.45%, while CeriBell does not currently pay one.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CBLL | CNMD |
|---|---|---|
| Share price | $23.48 | $44.23 |
| Market cap | $901.12M | $1.32B |
| 1-day change | -3.53% | -0.56% |
| YTD return | +7.07% | — |
| 1-year return | +98.98% | — |
| 5-year return | — | -68.86% |
| P/E ratio (TTM) | — | 23.91 |
| Forward P/E | — | 9.25 |
| EPS (TTM) | $-1.76 | $1.85 |
| Dividend yield | 0.00% | 0.45% |
| Annual dividend | $0.00 | $0.20 |
| 52-week high | $25.63 | $53.66 |
| 52-week low | $10.85 | $31.44 |
| Distance from 52-week high | -8.38% | -17.57% |
| Average volume | 369.87K | 493.85K |
| Shares outstanding | 38.38M | 29.95M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
CBLL vs CNMD FAQ
Which is bigger, CeriBell or CONMED?
CONMED (CNMD) is larger, with a market capitalization of $1.32B compared with $901.12M for CeriBell (CBLL).
Which pays a higher dividend, CeriBell or CONMED?
CONMED pays a dividend yielding 0.45%, while CeriBell does not currently pay a regular dividend.
Are CeriBell and CONMED in the same industry?
Yes. Both are classified in the Biotechnology: Electromedical & Electrotherapeutic Apparatus industry within the Health Care sector.